Health authorities in the German state of Schleswig-Holstein have asked wholesalers and pharmacies to recall a generic blood thinner, MarketWatch reported.
A spokesman for BfArM, the Federal Institute for Drugs and Medical Devices said that there was reason to suspect that the blood thinner, a generic version of heparin manufactured by small German firm Rotexmedica GmbH Arzneimittelwerk, was not of acceptable quality, according to MarketWatch.
Rotexmedica has so far declined to comment.
US based-Baxter International Inc last week announced that it was proceeding with a voluntary recall of its own heparin products, following a high number of reports of adverse patient reactions.
The US Food and Drug Administration is currently investigating the cause of adverse effects following heparin treatment, in US patients.